Evolving therapies in the treatment of hepatocellular carcinoma
Hans Christian Spangenberg, Robert Thimme, Hubert E BlumDepartment of Medicine II, University of Freiburg, D-79106 Freiburg, GermanyAbstract: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The major etiologies and risk factors for HCC development are well define...
Main Authors: | Hans Christian Spangenberg, Robert Thimme, Hubert E Blum |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-09-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | https://www.dovepress.com/evolving-therapies-in-the-treatment-of-hepatocellular-carcinoma-peer-reviewed-article-BTT |
Similar Items
Similar Items
-
Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma
by: Khalid A Jazieh, et al.
Published: (2014-01-01) -
Hepatocellular carcinoma - Global burden and risk factors
by: Hubert Blum
Published: (2007-02-01) -
Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report
by: Dorn Annette, et al.
Published: (2011-09-01) -
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01) -
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
by: E B Shakhnovich, et al.
Published: (2015-03-01)